Epidemiology, clinical features, antifungal resistance, and prognosis of fungemia in pediatric patients
DOI:
https://doi.org/10.3855/jidc.21010Keywords:
fungemia, prognosis, candidemia, pediatricAbstract
Introduction: The aim of this study was to investigate the epidemiology, clinical characteristics, antifungal susceptibility, and prognosis of fungemia among pediatric patients.
Methodology: A retrospective cohort analysis was conducted on 195 fungemia cases at Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital over a 7-year period (2016–2023). Comprehensive clinical data were extracted from the electronic medical record system.
Results: Microbiological analysis of 195 fungemia cases revealed 22 distinct fungal species. Candida parapsilosis was the predominant pathogen (28.2%, 55/195), followed by Candida albicans (26.7%, 52) and Candida tropicalis (10.8%, 21). The cohort demonstrated distinctive epidemiological features: median patient age of 30 days, neonatal predominance (40.5%), and male preponderance (60%). Alarmingly high antifungal resistance profiles were observed, particularly in C. albicans (66% fluconazole and 62% voriconazole resistance) and C. dubliniensis (82% itraconazole resistance). Non-albicans infections correlated with elevated intensive care unit (ICU) admission rates and neutropenia incidence, while C. albicans cases showed stronger associations with prematurity and low birth weight. The clinical course was marked by prolonged hospitalization (median 37 days), with 56.4% requiring intensive care and 20% developing persistent candidemia. 81.5% achieved clinical resolution, though 15.4% required non-medical transfers and 3.0% succumbed to refractory infections despite maximal therapy.
Conclusions: Neonates represented the highest-risk population for pediatric fungemia, with a median hospitalization duration of 37 days. Over half of the affected children (56.4%) required ICU admission. The high rate of antifungal resistance and poor prognosis underscore the urgent need for enhanced surveillance protocols and optimized antifungal stewardship in pediatric settings.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Chunyun Fu, Huan Zhang, Lishai Mo, Shuangjie Wang, Minxue Liu, Jing Guo, Chunhua Lan, Chenglan Yan, Caifang Ma, Xuehua Hu, Qifei Li
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
